{
    "root": "edf2accd-a18f-4f72-a2e7-77d478c37538",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Triamcinolone Acetonide",
    "value": "20250515",
    "ingredients": [
        {
            "name": "TRIAMCINOLONE ACETONIDE",
            "code": "F446C597KA"
        },
        {
            "name": "AQUA",
            "code": "059QF0KO0R"
        },
        {
            "name": "CETYL ALCOHOL",
            "code": "936JST6JCN"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "GLYCERYL MONOSTEARATE",
            "code": "230OU9XXE4"
        },
        {
            "name": "POLYSORBATE 60",
            "code": "CAL22UVI4M"
        },
        {
            "name": "SORBITAN MONOSTEARATE",
            "code": "NVZ4I0H58X"
        },
        {
            "name": "SORBIC ACID",
            "code": "X045WJ989B"
        },
        {
            "name": "ISOPROPYL PALMITATE",
            "code": "8CRQ2TH63M"
        },
        {
            "name": "CETYL ESTERS",
            "code": "D072FFP9GU"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        }
    ],
    "indications": "Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.",
    "contraindications": "Topical corticosteroids are generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition.\n                  Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressing should be discontinued and appropriate antimicrobial therapy instituted.",
    "warningsAndPrecautions": "Product:    50090-3704\n                  NDC:    50090-3704-0   15 g in a TUBE   /  1  in a  CARTON",
    "adverseReactions": "Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations."
}